🇺🇸 FDA
Pipeline program

Sevoflurane

TJMZK20120301

Approved small_molecule completed

Quick answer

Sevoflurane for Middle Aged Patients is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Middle Aged Patients
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials